Video Experimental Relacionado
Updated: May 31, 2026
09:27
Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains
Published on: January 5, 2016
La glucocerebrosidasa y la α-sinucleína de la enfermedad de Gaucher forman un bucle patógeno bidireccional en las
Joseph R Mazzulli1, You-Hai Xu, Ying Sun
1Department of Neurology, Massachusetts General Hospital, Harvard Medical School, MassGeneral Institute for Neurodegenerative Disease, Charlestown, MA 02129, USA.
Cell
|June 25, 2011
Resumen
La enfermedad de Parkinson está relacionada con la enfermedad de Gaucher a través de la glucocerebrosidasa (GCase). La pérdida de la función de la GCase afecta la degradación de las proteínas, causando la acumulación de alfa-sinucleína y la neurotoxicidad, lo que sugiere un mecanismo de enfermedad compartido.
Área de la Ciencia:
- Las enfermedades neurodegenerativas son enfermedades neurodegenerativas.
- Trastornos del almacenamiento lisosomal.
- Los mecanismos moleculares de la neurotoxicidad
Sus antecedentes:
- La enfermedad de Parkinson (EP) es un trastorno neurodegenerativo en adultos.
- Existe un vínculo clínico entre la enfermedad de Parkinson y la enfermedad de Gaucher (GD), un trastorno de almacenamiento lisosomal.
- La conexión mecánica entre PD y GD sigue siendo desconocida.
Objetivo del estudio:
- Investigar el vínculo mecánico entre la glucocerebrosidasa (GCase) relacionada con la enfermedad de Gaucher y la patogénesis de la enfermedad de Parkinson.
- Aclarar el papel de la disfunción de la GCasa en la agregación de alfa-sinucleína (α-syn) y la neurotoxicidad.
Principales métodos:
- Se utilizaron cultivos neuronales primarios y neuronas derivadas de células madre pluripotentes inducidas por humanos (iPS).
- Se evaluaron las vías de degradación de las proteínas lisosomales.
- Se investigó el impacto de la glucosilceramida (GlcCer) en la formación de amiloides α-sin.
- Examinó la actividad de GCase en el tejido cerebral de la PD idiopática.
Principales resultados:
- La pérdida funcional de GCase comprometió la degradación de las proteínas lisosomales.
- La deficiencia de GCase condujo a la acumulación de α-syn y la neurotoxicidad dependiente de la agregación.
- El sustrato de GCase, GlcCer, estabilizó los intermediarios oligoméricos α-syn, promoviendo la formación de amiloides.
- Se encontró que α-syn inhibe la actividad normal de GCase en las neuronas y el tejido cerebral de la PD.
Conclusiones:
- Existe un bucle de retroalimentación bidireccional entre α-syn y GCase, lo que podría impulsar la autopropagación de la enfermedad.
- El agotamiento de la GCase contribuye a la patogénesis de las sinucleinopatías esporádicas.
- Dirigir la administración de GCase a los lisosomas puede ofrecer una estrategia terapéutica específica para la EP y otras sinucleinopatías.
Videos de Conceptos Relacionados
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:22Lysosomal Hydrolases
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
01:23Cystic Fibrosis: Pathogenesis
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...